Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate
Key finding
Characterized a novel GHK-copper complex with enhanced physiological functionality, expanding the understanding of copper peptide bioactivity for therapeutic applications.
Key takeaways
- A new form of GHK-Cu was found that may work even better in the body.
- The body may naturally create enhanced versions of this copper peptide.
- This could lead to more effective anti-aging products in the future.
Study breakdown
The biological activity of GHK-Cu depends critically on the chemistry of how copper binds to the peptide and interacts with surrounding molecules. This study by Bossak-Ahmad, Wisniewska, Bal, and colleagues investigated a ternary complex formed between GHK peptide, copper, and cis-urocanic acid, a naturally occurring molecule found in skin.
The researchers characterized the structural and functional properties of this novel ternary complex using spectroscopic and analytical techniques. By examining how cis-urocanic acid participates in the copper-peptide interaction, they explored whether this three-component system could represent a physiologically relevant form of copper chelation in the body.
The findings revealed that the ternary GHK-copper complex with cis-urocanic acid possesses enhanced physiological functionality compared to simpler copper-peptide combinations. This discovery suggests that the body may naturally form these multi-component complexes to optimize copper delivery and bioactivity in tissues.
Understanding how GHK-Cu functions within the body's natural biochemistry is essential for developing more effective therapeutic formulations. This study expands the scientific foundation for copper peptide therapy by revealing how naturally occurring molecules can enhance GHK-Cu's biological activity, potentially informing the design of next-generation copper peptide preparations.
Read the full study on PubMed for complete methodology and data.
View full study on PubMedPMID: 32867146
More GHK-Cu research
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?
Ogorek K, Nowak K, Wadych E, et al. · Molecules (Basel, Switzerland)
Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application
Dymek M, Olechowska K, Hac-Wydro K, et al. · Pharmaceutics
The potential of GHK as an anti-aging peptide
Dou Y, Lee A, Zhu L, et al. · Aging Pathobiology and Therapeutics
Theoretical study of copper binding to GHK peptide
Alshammari N, Platts JA · Computational biology and chemistry
The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice
Park JR, Lee H, Kim SI, et al. · Oncotarget
Curious how this research applies to your goals?
Book a free consult with Dr. TaylorDisclaimer: This summary is educational only and is not medical advice. For complete methodology and data, refer to the original publication on PubMed. Always consult a qualified healthcare provider before making medical decisions.